Status:
UNKNOWN
Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.
Lead Sponsor:
Yonsei University
Conditions:
Primary Open Angle Glaucoma
Eligibility:
All Genders
10-90 years
Brief Summary
RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL and ganglion...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Evidence of retinal disease
- Neovascular glaucoma
- Secondary glaucoma due to intraocular inflammation
- Lens induced glaucoma
- Tumor induced glaucoma
Exclusion
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00773123
Start Date
October 1 2008
End Date
December 1 2008
Last Update
October 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University School of Medicine
Seoul, South Korea, 120-752